Related Experiment Videos

Cyclosporine immunosuppression and early kidney graft function

H H Neumayer¹, M Henkel, K Wagner

¹Department of Internal Medicine and Nephrology, Steglitz Medical Center, Free University of Berlin, FRG.

Transplantation Proceedings

|June 1, 1988

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Acute cellular rejection with isolated v-lesions is not associated with more favorable outcomes than vascular rejection with more tubulointerstitial inflammations.

Clinical transplantation·2014

Hypertension in renal allograft recipients.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia·2008

Reduced-exposure cyclosporine is safe and efficacious in de novo renal transplant recipients treated with enteric-coated mycophenolic acid and basiliximab.

Clinical nephrology·2007

Long-term safety and efficacy after conversion of maintenance renal transplant recipients from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPA, myfortic).

Clinical nephrology·2006

Differences in reporting of acute rejections between American and European publications of large immunosuppressive trials impair comparability of study results.

Transplantation proceedings·2005

Laparoscopic versus open donor nephrectomy in Germany: impact on donor health-related quality of life and willingness to donate.

Transplantation proceedings·2005

See all related articles